Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 68

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 68
---
 timely manner, or at all, and may face regulatory actions or other sanctions from the CSRC, the CAC or other PRC or Hong Kong regulatory authorities if we fail to fully comply with any new regulatory requirements. Consequently, our operations and financial condition could be materially adversely affected, and Living Homeopathy’s ability to offer securities to investors could be significantly limited or completely hindered and the securities currently being offered may substantially decline in value and become worthless.

We are aware that recently, the government
of mainland China initiated a series of regulatory actions and statements to regulate business operations in certain areas in mainland
China with little or no advance notice, including cracking down on illegal activities in the securities market, enhancing supervision
over mainland China-based companies listed overseas using variable interest entity structure, adopting new measures to extend the scope
of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement. Nevertheless, since these statements and regulatory
actions are new, it is highly uncertain how soon the legislative or administrative regulation making bodies will respond and what existing
or new laws or regulations or detailed implementations and interpretations will be modified or promulgated, if any. It is also highly
uncertain what potential impact such modified or new laws and regulations will have on Living Homeopathy Hong Kong’s daily business
operations, Living Homeopathy’s ability to accept foreign investments and the listing of the Class A Ordinary Shares on a U.S.
or other foreign exchanges. If there is significant change to current political arrangements between mainland China and Hong Kong, the
PRC government intervenes or influences operations of companies operated in Hong Kong like us, or exerts more control through change
of laws and regulations over offerings conducted overseas and/or foreign investment in issuers like Living Homeopathy, it may result
in a material change in our operations and/or the value of the securities Living Homeopathy is registering for sale or could significantly
limit or completely hinder Living Homeopathy’s ability to offer or continue to offer securities to investors and cause the value
of the Class A Ordinary Shares to significantly decline or become worthless.

<div align='center'>35</div>

Rules for cross-border provision and examination of auditing records and other materials in connection with overseas securities issuance and listing was released and became effective by the CSRC The government of mainland China may impose more stringent requirement for domestic Chinese companies to share business and accounting records with foreign auditing firms and other securities service institutions, which could significantly limit or completely hinder Living Homeopathy’s ability to offer or continue to offer its Class A Ordinary Shares to investors and